H. Dabernat

413 total citations
43 papers, 290 citations indexed

About

H. Dabernat is a scholar working on Epidemiology, Molecular Medicine and Microbiology. According to data from OpenAlex, H. Dabernat has authored 43 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 19 papers in Molecular Medicine and 17 papers in Microbiology. Recurrent topics in H. Dabernat's work include Pneumonia and Respiratory Infections (19 papers), Antibiotic Resistance in Bacteria (19 papers) and Bacterial Infections and Vaccines (16 papers). H. Dabernat is often cited by papers focused on Pneumonia and Respiratory Infections (19 papers), Antibiotic Resistance in Bacteria (19 papers) and Bacterial Infections and Vaccines (16 papers). H. Dabernat collaborates with scholars based in France, United States and Lebanon. H. Dabernat's co-authors include C. Delmas, J Lemozy, J. Sirot, D. Sirot, C. Chanal, Roger Labia, D. Tainturier, R. Bauriaud, Clément Delmas and V. Goulet and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

H. Dabernat

42 papers receiving 257 citations

Peers

H. Dabernat

EPIDE

MICRO

PHARM

S Ozeki Japan

B L Wetherall Australia

Véronique Rieux France

Providencia Joyanes Spain

M. C. Negri Spain

A Dickens United Kingdom

Shu-Man Yao Taiwan

F. Chau France

Andrea G. Albarracín Orio Argentina

Xiuyu Xu China

S Ozeki Japan

H. Dabernat

127 ×0.9

EPIDE

218 ×1.6

176 ×2.0

MICRO

128 ×1.9

PHARM

90 ×2.2

Citations per year, relative to H. Dabernat H. Dabernat (= 1×) peers S Ozeki

Countries citing papers authored by H. Dabernat

Since Specialization

Citations

This map shows the geographic impact of H. Dabernat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Dabernat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Dabernat more than expected).

Fields of papers citing papers by H. Dabernat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Dabernat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Dabernat. The network helps show where H. Dabernat may publish in the future.

Co-authorship network of co-authors of H. Dabernat

This figure shows the co-authorship network connecting the top 25 collaborators of H. Dabernat. A scholar is included among the top collaborators of H. Dabernat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Dabernat. H. Dabernat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lévy, Corinne, Édouard Bingen, F. de La Rocque, et al.. (2008). Des échecs des vaccinations contre les méningites bactériennes ?. Archives de Pédiatrie. 15(5). 545–547. 3 indexed citations

Soussy, Claude–James, F. W. Goldstein, H. Dabernat, et al.. (2003). In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study. Clinical Microbiology and Infection. 9(10). 997–1005. 18 indexed citations

Sirot, J., Marie-Hélène Nicolas-Chanoine, H. Chardón, et al.. (2002). Susceptibility of Enterobacteriaceae to β-lactam agents and fluoroquinolones: a 3-year survey in France. Clinical Microbiology and Infection. 8(4). 207–213. 25 indexed citations

Dabernat, H., et al.. (2002). Évaluation de l'activité in vitro de la télithromycine sur Haemophilus influenzae. Pathologie Biologie. 50(1). 58–62. 3 indexed citations

Paris, C., et al.. (2001). Méningite bactérienne à Haemophilus influenzae : le risque résiduel ; à propos d’un cas. Archives de Pédiatrie. 8(10). 1082–1085. 3 indexed citations

Nicolas-Chanoine, Marie-Hélène, Patrice Nordmann, A. Philippon, et al.. (2001). Multicenter Evaluation of an Automated System Using Selected Bacteria That Harbor Challenging and Clinically Relevant Mechanisms of Resistance to Antibiotics. European Journal of Clinical Microbiology & Infectious Diseases. 20(9). 626–635. 9 indexed citations

Dabernat, H., et al.. (1996). Analysis of oral antibiotic treatment that failed to prevent the development of Haemophilus influenzae meningitis: consequences on mortality. Journal of Antimicrobial Chemotherapy. 38(4). 679–689. 4 indexed citations

Lemozy, J, D. Sirot, C. Chanal, et al.. (1995). First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains. Antimicrobial Agents and Chemotherapy. 39(11). 2580–2582. 52 indexed citations

Dabernat, H. & C. Delmas. (1995). Haemophilus influenzae, le sérotype b et les autres. Médecine et Maladies Infectieuses. 25(3). 500–503. 8 indexed citations

10.

Saivin, Sylvie, et al.. (1992). [Resistance to antibiotic treatment produced in a model of experimental Pseudomonas aeruginosa peritonitis].. PubMed. 40(5). 573–82.

11.

Thabaut, A, Marie Chanal, A Buré, et al.. (1989). [In vitro antibacterial effect of a new oral cephalosporin, cefixime. Results of a multicenter study].. PubMed. 37(5 Pt 2). 528–33. 2 indexed citations

12.

Thabaut, A, et al.. (1986). Intérêt de la surveillance de la sensibilité des bactéries pathogènes en zone intertropicale dans le cadre d'une rationalisation du médicament essentiel. Médecine et Maladies Infectieuses. 16(4). 245–247. 7 indexed citations

13.

Prère, M.F., et al.. (1985). Présence de plasmideschez Neisseria meningitidis. Annales de l Institut Pasteur Microbiologie. 136(2). 271–276. 7 indexed citations

14.

Thabaut, A, et al.. (1985). [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].. PubMed. 33(5 Pt 2). 487–92. 2 indexed citations

15.

Delmas, C., et al.. (1985). Profil enzymatique et contenu plasmidique de «Neisseria polysacchareae». Annales de l Institut Pasteur Microbiologie. 136(1). 29–38. 1 indexed citations

16.

Dabernat, H.. (1984). Sensibilité du méningocoque aux antibiotiques. Médecine et Maladies Infectieuses. 14. 37–42. 1 indexed citations

17.

Dabernat, H., et al.. (1980). In vitro susceptibility of Haemophilus equigenitalis, the causative organism of contagious equine metritis 1977, to antimicrobial agents. Antimicrobial Agents and Chemotherapy. 18(6). 841–843. 14 indexed citations

18.

Dabernat, H., et al.. (1980). Comparative activities of cefotaxime, a new cephalosporin derivative, and of selected beta-lactam antibiotics against Haemophilus species.. PubMed. 130 A(4). 461–7. 5 indexed citations

19.

Dabernat, H., et al.. (1979). Yersinia enterocolitica fermenting rhamnose. About 15 strains isolated in children.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 5. 270–6. 4 indexed citations

20.

Avril, J, H. Dabernat, G Gerbaud, et al.. (1977). Groupes d'incompatibilité des plasmides r chez les souches de Salmonella épidémiques.. 128(2). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact